These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35731595)

  • 1. Novel 5-Fluorouracil Carbonate-Loaded Liposome: Preparation,
    Wang X; Wang A; Feng W; Wang D; Guo X; Wang X; Miao Q; Liu M; Xia G
    Mol Pharm; 2022 Jul; 19(7):2061-2076. PubMed ID: 35731595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of Rapamycin by Liposomes Synergistically Enhances the Chemotherapy Effect of 5-Fluorouracil on Colorectal Cancer.
    Chen YQ; Zhu WT; Lin CY; Yuan ZW; Li ZH; Yan PK
    Int J Nanomedicine; 2021; 16():269-281. PubMed ID: 33469286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
    Sen K; Banerjee S; Mandal M
    Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of smart solid lipid nanoparticles to enhance the efficacy of 5-fluorouracil in the treatment of colorectal cancer.
    Smith T; Affram K; Nottingham EL; Han B; Amissah F; Krishnan S; Trevino J; Agyare E
    Sci Rep; 2020 Oct; 10(1):16989. PubMed ID: 33046724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes.
    Sun W; Zhang N; Li A; Zou W; Xu W
    Int J Pharm; 2008 Apr; 353(1-2):243-50. PubMed ID: 18155370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel SN38 derivative-based liposome as anticancer prodrug: an in vitro and in vivo study.
    Wu C; Zhang Y; Yang D; Zhang J; Ma J; Cheng D; Chen J; Deng L
    Int J Nanomedicine; 2019; 14():75-85. PubMed ID: 30587986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation.
    Fanciullino R; Giacometti S; Mercier C; Aubert C; Blanquicett C; Piccerelle P; Ciccolini J
    Br J Cancer; 2007 Oct; 97(7):919-26. PubMed ID: 17848948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evaluation of lipofufol, a new triple stealth liposomal formulation of modulated 5-fu: impact on efficacy and toxicity.
    Fanciullino R; Mollard S; Giacometti S; Berda-Haddad Y; Chefrour M; Aubert C; Iliadis A; Ciccolini J
    Pharm Res; 2013 May; 30(5):1281-90. PubMed ID: 23386105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro co-delivery of 5-fluorouracil and all-trans retinoic acid by PEGylated liposomes for colorectal cancer treatment.
    Azarifar Z; Amini R; Tanzadehpanah H; Afshar S; Najafi R
    Mol Biol Rep; 2023 Dec; 50(12):10047-10059. PubMed ID: 37902908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol-Conjugate as a New Strategy to Improve the Cytotoxic Effect of 5-Fluorouracil on Liver Cancer: Impact of Liposomal Composition.
    Alanazi SA; Harisa GI; Badran MM; Haq N; Radwan AA; Kumar A; Shakeel F; Alanazi FK
    Curr Drug Deliv; 2020; 17(10):898-910. PubMed ID: 32072911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
    Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
    Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways.
    Shakibaei M; Mobasheri A; Lueders C; Busch F; Shayan P; Goel A
    PLoS One; 2013; 8(2):e57218. PubMed ID: 23451189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of chitosan-coated flexible liposomes as a remarkable carrier to enhance the antitumor efficacy of 5-fluorouracil against colorectal cancer.
    Alomrani A; Badran M; Harisa GI; ALshehry M; Alhariri M; Alshamsan A; Alkholief M
    Saudi Pharm J; 2019 Jul; 27(5):603-611. PubMed ID: 31297013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorbitan Monolaurate-Containing Liposomes Enhance Skin Cancer Cell Cytotoxicity and in Association with Microneedling Increase the Skin Penetration of 5-Fluorouracil.
    Crisóstomo LCCF; Carvalho GSG; Leal LKAM; de Araújo TG; Nogueira KAB; da Silva DA; de Oliveira Silva Ribeiro F; Petrilli R; Eloy JO
    AAPS PharmSciTech; 2022 Aug; 23(6):212. PubMed ID: 35918472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
    Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
    Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches.
    Vale N; Pereira M; Santos J; Moura C; Marques L; Duarte D
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative hybrid lipid nanosystem combining cytotoxic and magnetic properties as a tool to potentiate antitumor effect of 5-fluorouracil.
    Azevedo A; Coelho MP; Pinho JO; Soares PIP; Reis CP; Borges JP; Gaspar MM
    Life Sci; 2024 May; 344():122558. PubMed ID: 38471621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer.
    Yuan L; Zhang S; Li H; Yang F; Mushtaq N; Ullah S; Shi Y; An C; Xu J
    Biomed Pharmacother; 2018 Dec; 108():184-193. PubMed ID: 30219675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-cross-linked chitosan microspheres in colorectal cancer therapy in rats.
    Ganguly K; Kulkarni AR; Aminabhavi TM
    Drug Deliv; 2016 Oct; 23(8):2838-2851. PubMed ID: 26530807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.